Filing Details
- Accession Number:
- 0001345568-12-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-27 16:41:31
- Reporting Period:
- 2012-03-23
- Filing Date:
- 2012-03-27
- Accepted Time:
- 2012-03-27 16:41:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1053369 | Elite Pharmaceuticals Inc | ELTP | Pharmaceutical Preparations (2834) | 223542636 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1442002 | Epic Pharma Llc | 227-15 North Conduit Ave Laurelton NY 11413-3134 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-03-23 | 1,765,000 | $0.10 | 61,593,669 | No | 4 | S | Indirect | see footnote |
Common Stock | Disposition | 2012-03-26 | 225,000 | $0.09 | 61,368,669 | No | 4 | S | Indirect | see footnote |
Common Stock | Disposition | 2012-03-27 | 735,000 | $0.09 | 60,633,669 | No | 4 | S | Indirect | see footote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | see footnote |
No | 4 | S | Indirect | see footnote |
No | 4 | S | Indirect | see footote |
Footnotes
- The reporting person, Epic Pharma, LLC ("EP"), is an equity owner of Epic Investments, LLC ("EI"), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer. EP and EI are both owned, wholly or in part, and are operated by Ram Potti, Ashok G. Nigalaye and Jeenarine Narine, each of whom is a director of the issuer. The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.